Literature DB >> 10652609

CD1a positive putative tumour infiltrating dendritic cells in human breast cancer.

B J Coventry1.   

Abstract

CD1a molecules are expressed on dendritic cells (DC) during certain maturational phases coincident with the functions of antigen capture and processing. During these phases, CD1a is anchored to the cytoplasmic membrane through its cytoplasmic domain and the antigenic binding domain is projected from the cell surface. Membrane bound HLA Class I and II molecules are also expressed at relatively high levels on DC, but it is not known whether there is any interdependence between CD1 expression and that of the classical histocompatability molecules. Recent information concerning the structure, function and likely role of CD1 in presentation of hydrophobic lipid and carbohydrate antigens to the immune system is detailed. The potential relevance of the lipid presenting functions of CD1 molecules for the detection and recognition of tumour glycolipid antigens is hypothesised and discussed. CD1 a tumour infiltrating putative dendritic cells are discussed in terms of their density, separation, culture and possible function in breast cancers in the light of recent findings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10652609

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.

Authors:  Holbrook E Kohrt; Navid Nouri; Kent Nowels; Denise Johnson; Susan Holmes; Peter P Lee
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

2.  Dendritic cell density and activation status in human breast cancer -- CD1a, CMRF-44, CMRF-56 and CD-83 expression.

Authors:  B J Coventry; P-L Lee; D Gibbs; D N J Hart
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

3.  CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients.

Authors:  Vivian Labovsky; Norma Alejandra Chasseing; María Belén Giorello; Ayelén Matas; Pablo Marenco; Kevin Mauro Davies; Francisco Raúl Borzone; María de Luján Calcagno; Hernán García-Rivello; Alejandra Wernicke; Leandro Marcelo Martinez
Journal:  Breast Cancer       Date:  2021-07-09       Impact factor: 4.239

4.  CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer.

Authors:  B J Coventry; J Morton
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

5.  Polymorphism in Exon 2 of CD1 Genes in Southwest of Iran.

Authors:  Hossein Golmoghaddam; Nargess Arandi; Abbas Ghaderi; Mehrnoosh Doroudchi
Journal:  Iran J Public Health       Date:  2013-07-01       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.